參考文獻 References

1. Liu, Y., Zhang, L., Li, L., & Cui, J. (2020). Overview of the Development of EGFR-Tyrosine Kinase Inhibitor for Non-Small Cell Lung Cancer. Journal of Cancer Research and Clinical Oncology, 146(3), 691–701.
2. J?nne, P. A., Yang, J. C.-H., Kim, D.-W., et al. (2015). AZD9291 in EGFR inhibitor–resistant non–small-cell lung cancer. New England Journal of Medicine, 372(18), 1689-1699.
3. Mok, T. S., Wu, Y.-L., Thongprasert, S., et al. (2009). Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma. New England Journal of Medicine, 361(10), 947-957.